Omnicell Inc. announced that it will release its financial results for the third quarter of fiscal year 2026 before market open on Thursday, October 29, 2026. The healthcare technology provider will host a conference call and webcast to discuss these results at 8:30 am ET on the same day.

Conference call details

Interested parties can access the live call and presentation by dialing (833) 461-5787 within the United States or (585) 542-9983 for international locations. The conference ID for the call is 574173299.

A link to the live and archived webcast will be available on the Investor Relations section of the company's website. Investors are advised to check the official investor relations portal for direct access to the presentation materials.

Company profile

Since 1992, Omnicell has focused on delivering innovative pharmacy and nursing solutions across all settings of care. As an intelligent medication management technology company, it empowers autonomous medication management by unifying automation and AI-enabled intelligence with expert services.

The company aims to drive clinical and business outcomes that improve efficiency and enhance patient safety for healthcare facilities worldwide.

Omnicell, Inc. (NASDAQ: OMCL) will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.

The presentation is scheduled for 12:45 p.m. EDT. Investors and analysts can access the event through live and archived webcasts available on the Omnicell website.

Event Details

Omnicell, a healthcare technology provider focused on autonomous medication management, confirmed its participation in the conference. The company aims to share updates with stakeholders during the session.

Accessing the Presentation

• Live webcast: Available via Omnicell’s investor relations portal.
• Archived recording: Posted on the same platform following the event.

Investor relations inquiries should be directed to David Unger at ir@omnicell.com .